Success Stories
Highlights of the PCI news focused on Penn commercialization accomplishments
Highlights of the PCI news focused on Penn commercialization accomplishments
PCI Ventures updated its flagship programs this past year that support University startups.
Drew Weissman, MD, PhD, the Roberts Family Professor of Vaccine Research, and Katalin Karikó, PhD, an adjunct professor of Neurosurgery at Penn, have been awarded multiple prestigious prizes.
iladelphia landed a spot in the overall top 30 of Startup Genome's Global Startup Ecosystem Report. The city scored highest for its market reach and talent.
chers have developed a highly-sensitive rapid antigen test that can detect small loads of SARS-CoV-2
A BioNTech-led team designed a cocktail of mRNAs that instruct cells to produce four cancer-fighting molecules.
Sixteen years after their research at Penn paved the way for billions to be vaccinated against COVID-19, two scientists from Penn have been honored with the Breakthrough Prize.
PCI is proud to announce that Penn is one of the schools chosen to participate in the National Science Foundation’s new innovative I-Corps Hub initiative.
The award, one of the largest in medicine and science in the U.S., has been given for the last 20 years by Albany Medical Center to those who have altered and positively impacted the course
The U.S. FDA has given the first full approval to a COVID-19 mRNA vaccine, which uses modified mRNA technology invented and developed by scientists at Penn.